1. Richard JG. Current Therapy in Nephrology and Hypertension. The CV Mosby Company. 1984-1985; 324–33.
2. Hayreh SS, Servais GE, Virdi PS, et al. Fundus lesions in malig-nant hypertension: III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology. 1986; 93:45–59.
Article
3. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hy-pertension: VI. Hypertensive choroidopathy. Ophthalmology. 1986; 93:1383–400.
Article
4. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hy-pertension: V. Hypertensive optic neuropathy. Ophthalmology. 1986; 93:74–87.
Article
5. De Venecia G, Jampol LM. The eye in accelerated hypertension: II. Localized serous detachments of the retina in patients. Arch Ophthalmol. 1984; 102:68–73.
Article
6. Levin LA, Kaufman PL. Adler's physiology of the EYE: Clinical Application. 11th ed.New York: Saunders/Elsevier;2011. p. 254–255.
Article
7. Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146:496–500.
Article
8. Jung JW, Chin HS, Lee DH, et al. Changes in subfoveal choroidal thickness and choroidal extravascular density by spectral domain optical coherence tomography after haemodialysis: a pilot study. Br J Ophthalmol. 2014; 98:207–12.
Article
9. Tanabe H, Ito Y, Iguchi Y, et al. Correlation between cross-sectional shape of choroidal veins and choroidal thickness. Jpn J Ophthalmol. 2011; 55:614–9.
Article
10. Usui S, Ikuno Y, Akiba M, et al. Circardian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012; 53:2300–7.
11. Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroi-dal thickness in normal, healthy subjects measured by spectral do-main optical coherence tomography. Invest Ophthalmol Vis Sci. 2012; 53:261–6.
12. Wei WB, Xu L, Shao L, et al. Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology. 2013; 120:175–80.
13. Fujiwara A, Shiragami C, Shirakata Y, et al. Enhanced depth imaging spectral-domain optical coherence tomography of subfoveal choroidal thickness in normal Japanese eyes. Jpn J Ophthalmol. 2012; 56:230–5.
Article
14. Suto K, Iida T, Hagimura N, Kishi S. Indocyanine green angio-graphic findings of hypertensive choroidopathy. Jpn J Clin Ophthalmol. 2001; 55:146–8.
Article
15. Chung SE, Kang SW, Kim JH, et al. Engorgement of vortex vein and polypoidal choroidal vasculopathy. Retina. 2013; 33:834–40.
Article
16. Kuroda S, Ikuno Y, Yasuno Y, et al. Choroidal thickness in central serous chorioretinopathy. Retina. 2013; 33:302–8.
Article
17. Pogrzebielski A, Lubaszewski W, Starzycka M, Kawecka-Jaszcz K. Fluorophotometric evaluation of blood-retinal barrier perme-ability in patients with essential hypertension. Ophthalmologica. 2004; 218:180–4.
Article
18. Jampol LM, White S, Cunha-Vaz J. Vitreous fluorophotometry in patients with hypertension. Arch Ophthalmol. 1983; 101:888–90.
Article
19. Murphy RP, Lam LA, Chew EY. Hypertension. In : Ryan SJ, editor. Retina. 4th ed.2:Medical Retina. Philadelphia: Elsevier Mosby;2006.
Article
20. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates. Ophthalmology. 1986; 93:60–73.
Article